1. Home
  2. GBIO vs LCW Comparison

GBIO vs LCW Comparison

Compare GBIO & LCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • LCW
  • Stock Information
  • Founded
  • GBIO 2016
  • LCW 2021
  • Country
  • GBIO United States
  • LCW United States
  • Employees
  • GBIO N/A
  • LCW N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • LCW Blank Checks
  • Sector
  • GBIO Health Care
  • LCW Finance
  • Exchange
  • GBIO Nasdaq
  • LCW Nasdaq
  • Market Cap
  • GBIO 145.5M
  • LCW 165.8M
  • IPO Year
  • GBIO 2020
  • LCW 2021
  • Fundamental
  • Price
  • GBIO $2.17
  • LCW $10.99
  • Analyst Decision
  • GBIO Buy
  • LCW
  • Analyst Count
  • GBIO 4
  • LCW 0
  • Target Price
  • GBIO $7.50
  • LCW N/A
  • AVG Volume (30 Days)
  • GBIO 61.6K
  • LCW 33.4K
  • Earning Date
  • GBIO 08-07-2024
  • LCW 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • LCW N/A
  • EPS Growth
  • GBIO N/A
  • LCW N/A
  • EPS
  • GBIO N/A
  • LCW N/A
  • Revenue
  • GBIO $13,174,000.00
  • LCW N/A
  • Revenue This Year
  • GBIO $99.36
  • LCW N/A
  • Revenue Next Year
  • GBIO N/A
  • LCW N/A
  • P/E Ratio
  • GBIO N/A
  • LCW N/A
  • Revenue Growth
  • GBIO 1397.05
  • LCW N/A
  • 52 Week Low
  • GBIO $0.86
  • LCW $10.58
  • 52 Week High
  • GBIO $4.83
  • LCW $11.03
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 38.49
  • LCW 50.96
  • Support Level
  • GBIO $2.26
  • LCW $11.00
  • Resistance Level
  • GBIO $2.49
  • LCW $11.02
  • Average True Range (ATR)
  • GBIO 0.22
  • LCW 0.01
  • MACD
  • GBIO -0.04
  • LCW -0.00
  • Stochastic Oscillator
  • GBIO 4.94
  • LCW 50.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About LCW Learn CW Investment Corporation

Learn CW Investment Corp is a blank check company. It is formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: